Characteristics of early-onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes. 2020

Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
Department of Gastroenterological Surgery Graduate School of Medicine Osaka University Osaka Japan.

The incidence of pancreatic cancer is high among those in their sixties to seventies but low in those in their fifties or younger. Although there is no unified definition regarding the age of early-onset pancreatic cancer, previously published reports suggest that, compared to later-onset pancreatic cancer patients, early-onset pancreatic cancer patients tend to be detected at advanced stages and thus have poor prognoses, but they do not show significantly higher rates of patients with genetic factors. On the other hand, it has been reported that patients with familial pancreatic cancer and hereditary pancreatic cancer syndromes often develop pancreatic cancer at a young age. The broad definition of familial pancreatic cancer is pancreatic cancer in patients who have two or more first-degree relatives with pancreatic cancer; whereas the narrow definition of familial pancreatic cancer is the broad definition of familial pancreatic cancer, while excluding those with inherited tumor syndromes. Hereditary tumors developing pancreatic cancer include hereditary pancreatitis, hereditary breast and ovarian cancer, Peutz-Jeghers syndrome, familial atypical multiple mole melanoma syndrome, familial adenomatous polyposis, and hereditary non-polyposis colorectal cancer, all of which are autosomal dominant hereditary diseases. This study reviews the clinical characteristics of early-onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes.

UI MeSH Term Description Entries

Related Publications

Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
November 2018, Cancer prevention research (Philadelphia, Pa.),
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
January 2019, International journal of molecular sciences,
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
January 2022, International journal of molecular sciences,
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
June 2020, Oncology (Williston Park, N.Y.),
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
October 2015, Surgical oncology clinics of North America,
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
November 2008, The Urologic clinics of North America,
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
June 2006, Endocrinology and metabolism clinics of North America,
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
November 2011, Journal of gastroenterology,
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
January 1997, Digestion,
Hidetoshi Eguchi, and Shogo Kobayashi, and Kunihito Gotoh, and Takehiro Noda, and Yuichiro Doki
June 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!